Research institutions throughout the world must have access to the latest developing research on SARS-CoV-2 in order to provide treatment to vulnerable populations, such as pregnant women. Transparent reporting of scientific research greatly increases the accuracy of data and provides a foundation from which stronger public health interventions can be achieved. Information gleaned from surveillance systems and research will educate medical professionals, allowing them to update clinical procedures and protocols. It is essential that more data is collected in order to determine the significance of the SARS-CoV-2 pandemic on pregnant women and infants.